Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01614405
What this trial is testing

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary Cirrhosis
University of Alberta 13
Testing effectiveness (Phase 2)Study completedNCT00059462
What this trial is testing

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

Who this might be right for
HIV Infections
Bayer 56
Early research (Phase 1)Study completedNCT05144386
What this trial is testing

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Who this might be right for
HIV-1-infection
Excision BioTherapeutics 6
Post-approval studies (Phase 4)UnknownNCT05122754
What this trial is testing

Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV-1-infection
Shanghai Public Health Clinical Center 150
Not applicableStudy completedNCT00001103
What this trial is testing

HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs

Who this might be right for
Cognitive DisordersHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT07792070
What this trial is testing

Pilot Study to Evaluate the Decentralization of Patient Care Among People With HIV in Out-of-hospital Settings

Who this might be right for
HIVHIV Antiretroviral Therapy (ART) AdherenceHealth Care Delivery
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 54
Testing effectiveness (Phase 2)Study completedNCT00721305
What this trial is testing

Lovastatin: Immunomodulatory Value Evaluation

Who this might be right for
HIV Seropositivity
Universidad de Antioquia 112
Testing effectiveness (Phase 2)UnknownNCT02551523
What this trial is testing

Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection

Who this might be right for
MonotherapyDolutegravirPrimary HIV Infection+1 more
University of Zurich 101
Large-scale testing (Phase 3)Ended earlyNCT00443703
What this trial is testing

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 352
Not applicableStudy completedNCT05310773
What this trial is testing

Couples Health CoOp Plus

Who this might be right for
HIVSubstance UseStigma, Social
RTI International 962
Testing effectiveness (Phase 2)Study completedNCT01335191
What this trial is testing

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)

Who this might be right for
HIV Infections
Thymon, LLC 27
Post-approval studies (Phase 4)Study completedNCT00466258
What this trial is testing

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV InfectionsDiffuse Large B Cell Lymphoma
PETHEMA Foundation 50
Large-scale testing (Phase 3)Study completedNCT01967940
What this trial is testing

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

Who this might be right for
HIVHIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 55
Not applicableStudy completedNCT01168167
What this trial is testing

Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation

Who this might be right for
HIV-1
Christoph Stephan 20
Large-scale testing (Phase 3)Study completedNCT01363011
What this trial is testing

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 106
Testing effectiveness (Phase 2)Temporarily pausedNCT06071767
What this trial is testing

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableLooking for participantsNCT06027671
What this trial is testing

Structured Peer-delivered ART and Reentry Community Strategy

Who this might be right for
Retention in Care
Johns Hopkins University 400
Not applicableStudy completedNCT01526421
What this trial is testing

Use of Incentives to Engage Drug Users in HIV Therapy

Who this might be right for
HIV Infection
University of British Columbia 301
Not applicableUnknownNCT05687565
What this trial is testing

Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV

Who this might be right for
HIV Infections
Hospital Universitari Vall d'Hebron Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00267865
What this trial is testing

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Who this might be right for
AIDS-Related-Primary Central Nervous System Lymphoma
National Cancer Institute (NCI) 12
Next Page